SHERBURN GROUP PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: B82031 | LEEDS, LS25 6ED
Showing results 51-100 of 638
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Desogestrel | 1,075 | 88.4K | £2.6K | +171.2% ▲ |
| 1,037 | 11.9K | £4.5K | +315.6% ▲ | |
| Other emollient preparations | 1,030 | 502.5K | £6.4K | +71.5% ▲ |
| Finasteride | 1,002 | 27.6K | £1.0K | +53.0% ▲ |
| Ferrous fumarate | 995 | 62.0K | £2.3K | +37.3% ▲ |
| Budesonide | 973 | 1,164 | £27.9K | +79.5% ▲ |
| Isosorbide mononitrate | 929 | 26.8K | £3.9K | +40.6% ▲ |
| Glucose blood testing reagents | 872 | 70.4K | £8.7K | +10.5% ▲ |
| Bendroflumethiazide | 868 | 23.6K | £400 | +12.2% ▲ |
| Gliclazide | 863 | 51.4K | £1.3K | +1.4% vs avg |
| Morphine sulfate | 851 | 140.9K | £4.7K | +29.8% ▲ |
| Famotidine | 836 | 27.6K | £16.1K | +71.3% ▲ |
| Spironolactone | 799 | 19.2K | £3.6K | +48.2% ▲ |
| Ibuprofen | 788 | 77.8K | £1.5K | +54.9% ▲ |
| Hydrocortisone | 754 | 24.1K | £7.6K | +68.1% ▲ |
| Doxazosin mesilate | 753 | 30.8K | £1.6K | -29.5% ▼ |
| Pregabalin | 753 | 44.9K | £2.3K | -40.0% ▼ |
| Atenolol | 748 | 23.4K | £522 | +24.1% ▲ |
| Alendronic acid | 736 | 2,968 | £755 | -1.9% vs avg |
| Felodipine | 726 | 20.2K | £3.2K | +22.3% ▲ |
| Warfarin sodium | 724 | 32.1K | £1.1K | +53.5% ▲ |
| Fluticasone furoate/vilanterol | 722 | 730 | £17.9K | +366.4% ▲ |
| Loratadine | 714 | 26.5K | £664 | +241.7% ▲ |
| 713 | 1,444 | £50.0K | +30.8% ▲ | |
| Flucloxacillin sodium | 681 | 27.8K | £1.6K | +51.4% ▲ |
| Doxycycline hyclate | 680 | 11.0K | £1.7K | +32.7% ▲ |
| Sildenafil (Erectile Dysfunction) | 674 | 4,586 | £651 | +33.7% ▲ |
| Venlafaxine | 672 | 31.6K | £4.8K | -20.5% ▼ |
| Hydroxocobalamin | 661 | 859 | £1.8K | +37.4% ▲ |
| Combined ethinylestradiol 30mcg | 625 | 39.9K | £2.0K | +125.0% ▲ |
| Diltiazem hydrochloride | 619 | 20.5K | £4.9K | +101.6% ▲ |
| Sitagliptin | 619 | 15.8K | £1.2K | +58.7% ▲ |
| 616 | 134.2K | £5.5K | +184.8% ▲ | |
| Estradiol with progestogen | 612 | 16.5K | £14.3K | +79.6% ▲ |
| 598 | 1,599 | £887 | +485.4% ▲ | |
| Ezetimibe | 586 | 16.7K | £3.0K | -17.6% ▼ |
| Ferrous sulfate | 583 | 24.4K | £821 | +13.4% ▲ |
| 577 | 577 | £25.2K | +85.8% ▲ | |
| Sacubitril/valsartan | 574 | 24.1K | £38.3K | +139.7% ▲ |
| Sumatriptan succinate | 567 | 3,850 | £2.4K | +60.1% ▲ |
| Estradiol | 555 | 13.9K | £6.6K | +105.7% ▲ |
| Lamotrigine | 550 | 31.2K | £5.4K | -6.9% ▼ |
| Fluticasone furoate | 548 | 571 | £3.9K | +182.9% ▲ |
| Glyceryl trinitrate | 546 | 759 | £1.4K | +130.8% ▲ |
| Fluticasone propionate (Inhalation) | 540 | 578 | £14.2K | +39.6% ▲ |
| Rivaroxaban | 536 | 16.0K | £11.2K | -12.4% ▼ |
| Pravastatin sodium | 516 | 13.7K | £669 | +58.9% ▲ |
| Buprenorphine | 504 | 2,170 | £12.2K | +37.6% ▲ |
| 502 | 3,905 | £1.5K | +140.2% ▲ | |
| Mirabegron | 483 | 13.2K | £12.0K | +20.2% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.